Screening for Chronic Kidney Disease in Cardiology Departments: Real-World Findings From a Multicenter Registry
A multicenter registry study of nearly 5,000 cardiology patients demonstrates that routinely combining urinary albumin-to-creatinine ratio (UACR) testing with estimated glomerular filtration rate (eGFR) significantly improves the early detection of chronic kidney disease and facilitates the timely initiation of protective SGLT2 inhibitor therapy compared to relying on eGFR alone.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, doctors have relied on a single blood test to gauge the health of the kidneys. This test measures how well the organs filter waste from the blood, a function known as the estimated glomerular filtration rate. While this number is vital, it tells only part of the story. The kidneys are also sensitive to tiny leaks of protein, specifically a substance called albumin, which can escape into the urine long before the filtering ability of the organ begins to drop. This early leakage, known as albuminuria, acts as a warning sign of structural damage that the blood test alone often misses. Because the heart and kidneys work in such close partnership, damage to one frequently signals trouble for the other, creating a complex web of risk that includes high blood pressure and diabetes. When these conditions overlap, the risk of heart failure and kidney failure rises sharply, yet the early stages of this decline often go unnoticed in routine medical care.
A recent investigation conducted across four specialized heart hospitals in Bulgaria sought to change how this hidden damage is found. The researchers focused on nearly five thousand patients who had been admitted to cardiology departments for various heart-related issues. Instead of relying solely on the standard blood test for kidney function, the team added a simple urine test to measure the ratio of albumin to creatinine. This combined approach allowed them to see a much clearer picture of kidney health than the traditional method ever could. By looking at both the blood and the urine, the study aimed to identify patients with early kidney damage who would otherwise have been overlooked, and to see if finding these patients sooner could lead to better treatment.
The results revealed that kidney problems are far more common among heart patients than previously recognized when using only the blood test. Nearly thirty percent of the patients showed a decline in their filtering ability, but an additional thirty percent had the telltale signs of albumin leakage in their urine despite having normal blood test results. This second group represented individuals with early structural damage to their kidneys that the standard screening would have completely missed. The study found that relying on the blood test alone would have left these patients unidentified, delaying the chance to intervene before their condition worsened.
Once the researchers identified these patients, they consulted with kidney specialists to determine the best course of action. The findings showed that this more thorough screening directly influenced treatment decisions. More than a quarter of the total group, representing over twelve hundred patients, were started on a specific class of medication known as SGLT2 inhibitors. These drugs are designed to protect both the heart and the kidneys, slowing the progression of disease and reducing the risk of hospitalization. The data indicated that the patients who were most likely to receive this life-saving treatment were those who showed signs of both reduced filtering ability and elevated albumin in their urine. However, the study also noted that patients with only the urine leakage, but normal blood filtration, were less likely to be started on the medication, highlighting a gap in current treatment patterns that more consistent screening could help close.
The study underscores a critical shift in how heart specialists view patient care. It demonstrates that the heart and kidneys are so deeply interconnected that a specialist treating one organ must also be vigilant about the other. The research suggests that adding a simple urine test to the standard blood work is not just an extra step, but a necessary one for catching disease in its earliest, most treatable stages. By adopting this combined approach, doctors can identify high-risk patients sooner, stratify their risks more accurately, and begin protective therapies before irreversible damage occurs. The authors conclude that this strategy, which is both simple and clinically sound, should become a standard part of the routine checkup for anyone at high risk of cardiovascular disease, ensuring that the silent warning signs of kidney damage are no longer ignored.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.